4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001507650-25-000003
Co-Chief Executive Officer bought 26,680 shares at $18.74 ($499,983)
- Co-Chief Executive Officer acquired 14,247,597 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Zanganeh Mahkam · Co-Chief Executive Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-21 | Grant or award : show line 1 in the form | +266,808 | $18.74 | $4,999,982 | 25,724,474 | I |
| 2025-10-21 | Purchase : show line 2 in the form | +26,680 | $18.74 | $499,983 | 76,680 | I |
| 2025-10-21 | Grant or award : show line 3 in the form | +13,980,789 | $18.74 | $261,999,986 | 570,073,879 | I |
| Open-market purchases · 26,680 sh · avg $18.74 · $499,983 | ||||||
Loading xslF345X05/wk-form4_1761249988.xml…